![T1D Exchange on X: "Great news for parents of children with type 1 diabetes - the FDA has granted approval for Fiasp, Novo's ultra fast-acting insulin, to be used with children! https://t.co/Dch9ns2NVd T1D Exchange on X: "Great news for parents of children with type 1 diabetes - the FDA has granted approval for Fiasp, Novo's ultra fast-acting insulin, to be used with children! https://t.co/Dch9ns2NVd](https://pbs.twimg.com/media/ENsv38YXkAEtjcs.jpg)
T1D Exchange on X: "Great news for parents of children with type 1 diabetes - the FDA has granted approval for Fiasp, Novo's ultra fast-acting insulin, to be used with children! https://t.co/Dch9ns2NVd
Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Lon
![PDF] Comment on “Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long Acting versus Short-Acting Insulins?” | Semantic Scholar PDF] Comment on “Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long Acting versus Short-Acting Insulins?” | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/aacefe9a0ceaf6da3d11df14663b5bbc0c56547c/2-Figure1-1.png)
PDF] Comment on “Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long Acting versus Short-Acting Insulins?” | Semantic Scholar
![Insulin Pen Injection Devices for Management of Patients with Type 2 Diabetes: Considerations Based on an Endocrinologist's Practical Experience in the United States - ScienceDirect Insulin Pen Injection Devices for Management of Patients with Type 2 Diabetes: Considerations Based on an Endocrinologist's Practical Experience in the United States - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1530891X20428198-gr1.jpg)